Sodium fluoride

Selected 1.1% toothpaste is labeled for once-daily dental caries prevention; selected 0.2% rinse is for weekly topical prevention. Both are dental products to spit out, not systemic fluoride therapy. Adult and child directions differ; professional varnishes, routine OTC dentifrices, and combination sensitive-teeth products are outside this selected scope.

All three selected SPL records are listed as unapproved drug other; their presence on DailyMed does not establish FDA approval. The chewable label describes pediatric supplementation in low-fluoride-water settings. FDA currently recommends ingestible fluoride only from age 3 for children at high risk of decay and states intended compliance action against labeling outside those limits. AAPD’s October 2025 statement continues its risk/exposure-based supplementation recommendations, including disagreement with the age restriction. These positions are explicitly separate, not a fabricated consensus.

Follow the specific product and dentist’s plan; do not swallow either preparation.

Doses refer to mg of fluoride ion, not mg of sodium fluoride salt. Selected dispensed tablet contains 1 mg fluoride from 2.2 mg sodium fluoride. Label-wide table also mentions 0.25/0.5 mg fluoride products, but they are not the selected package; separate formulations must be verified. Dissolve in the mouth or chew before swallowing, preferably bedtime after brushing. Avoid dairy within 1 hour as labeled. Assess caries risk, water from all sources, food/drinks, and swallowed toothpaste before prescribing; current FDA scope is age ≥ 3/high risk.

The following summarizes the label’s daily fluoride-ion schedule, with its age boundary preserved. Do not use any strength under 3 or treat the table as a reason to supplement children without high caries risk. At exactly 6, the label’s 3–6 versus > 6 table differs from the AAPD table beginning its older band at 6: obtain prescriber clarification rather than infer a new boundary.

Toothpaste and rinse labels direct against under 6 use unless a dentist/physician recommends it; below 6 effectiveness/safety is unestablished. Rinse additionally contraindicates dysphagia. Chewable label contraindicates all strengths under 3 and lists strength/water restrictions: 1 mg when water > 0.3 ppm or child under 6;0.5 mg when water > 0.6 ppm or under 6 with water ≥ 0.3 ppm;0.25 mg when water > 0.6 ppm. Its age/water table must also be followed; no adult chewable indication is supplied.

No selected SPL contains a boxed warning. Unapproved status, age/formulation restrictions, swallowed-exposure toxicity, and fluorosis remain clinically important.

Rare allergy/rash is reported; rinse flavor may irritate hypersensitive gingival tissue with mucositis. Large ingestion can cause mouth burning, nausea, vomiting, diarrhea, and serious toxicity. Legacy labels advise induced vomiting, which conflicts with current poison-center first aid: do not induce vomiting; immediately contact U.S. Poison Help 1-800-222-1222 for substance/amount/weight-specific advice. Call 911 for collapse, seizure, breathing difficulty, or inability to awaken. No home mg/kg triage or antidote procedure is propagated.

The tablet label directs no dairy within 1 hour because calcium can form poorly absorbed calcium fluoride. No other universal interaction interval or automatic dose increase is established. The topical labels do not authorize substituting a swallowed supplement when a rinse or paste is difficult to use.

Before prescribing supplements, review water from home/daycare/school, foods and drinks, and toothpaste ingestion. Do not add fluoride to a regimen without reconciling those sources and caries risk. The selected labels contain no comprehensive drug-interaction trial set; absence of one is not proof of safety for every combination.

Selected labels retain older pregnancy-category language and limited human controlled data; animal findings do not prove a safe systemic pregnancy dose. Labels advise nursing caution and do not establish human milk quantities. Topical spit-out dental care is distinct from supplementation, and the selected chewable is not indicated for adults. This profile does not claim a current LactMed consensus.

Follow the distinct ages and supervision instructions above. FDA’s ingestible restriction and AAPD’s differing policy must be considered separately; no under 3 supplement regimen is supplied here. Older topical-product patients may have reduced kidney function and greater toxicity susceptibility if swallowed; the tablet label has no geriatric indication.

Fluoride is substantially renally excreted; topical labels advise care in older patients with impaired renal function and note renal monitoring may help. None supplies a validated CrCl-stage or hepatic-stage adjustment schedule. Prevent swallowed excess and obtain individualized dental/medical review rather than convert topical concentration into a systemic renal regimen.

Topical fluoride reduces acid dissolution, supports remineralization, and affects cariogenic microbial activity. The chewable label describes systemic pre-eruption and topical post-eruption effects. This does not establish that more swallowed fluoride is better or remove the current age/risk restrictions.

The selected labels do not supply validated product-specific bioavailability, peak, or serum half-life data. Fluoride-ion content differs from sodium fluoride salt mass: 1 mg fluoride corresponds to 2.2 mg salt in the covered tablet. The rinse’s 0.2% sodium fluoride is labeled 0.09% fluoride ion; it is not a 0.2% fluoride-ion supplement. No serum PK value or oral/topical dose equivalence is invented.

Follow dental caries activity, adherence/technique, swallowing ability, and signs of allergy or fluorosis. For supplements, reassess water/diet/toothpaste exposure and the age/risk-based indication. Consider renal function when topical-label geriatric precautions are relevant; no universal laboratory interval is supplied.

Use only the prescribed concentration/route and supervise children. Toothpaste adult and pediatric rinse instructions differ; weekly rinse is not swallowed or taken daily. Keep full packages inaccessible to children. Confirm supplement fluoride-ion units and any age/water boundary uncertainty. For significant ingestion call Poison Help 1-800-222-1222 immediately; do not induce vomiting.

Colgate PreviDent 5000Plus 1.1% toothpaste: 51 g tubes, spearmint NDC 0126-0287-66 or Fruitastic 0126-0286-66. Alcohol-free PreviDent 0.2% rinse: 473 mL child-resistant bottle NDC 0126-0033-16. Bryant Ranch repackaged 1 mg fluoride chewable:orange-flavored white/off-white round M162 tablet, 120-count NDC 72162-1654-2. Repackager identity does not prove other strengths or current FDA approval.

Covered: 1.1% sodium fluoride dental paste, 0.2% sodium fluoride dental rinse, and 1 mg fluoride-ion chewable (2.2 mg sodium fluoride). Lower supplement strengths are described only as separate label schedules requiring their own dispensing check. OTC 0.05% rinse, lower-strength toothpaste, drops, varnishes, and combination products require their own labels.

Paste/rinse: 20–25°C. Chewable: 25°C with 15–30°C excursions, protect from light/moisture. Rinse package specifies original container or amber glass and no use if printed neck band is missing/broken. Keep children away from all packages and preserve the labeled route; no unsupported opened-package shelf life is supplied.